Publicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (14)

2023

  1. Diverticulitis with abscess formation: Outcomes of non-operative management and nomogram for predicting emergency surgery: The Diplicab Study Collaborative Group

    Surgery (United States), Vol. 174, Núm. 3, pp. 492-501

2020

  1. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224

2018

  1. Intravenous iron, functional recovery and delirium in patients with hip fracture. FEDEREF study. Single-centre randomised, placebo-controlled, and double-blind clinical trial. 2014-001923-53: EudraCT number

    Revista Espanola de Geriatria y Gerontologia, Vol. 53, Núm. 1, pp. 38-44

2015

  1. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

2014

  1. Análisis de 38 casos de traqueobronquitis en pacientes inmunocompetentes con doble aislamiento de Aspergillus en muestras de tracto respiratorio inferior

    Revista Espanola de Quimioterapia, Vol. 27, Núm. 2, pp. 110-114

  2. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

2011

  1. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849

2009

  1. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 6, pp. 920-925

2007

  1. Antimicrobial susceptibilities of amoxycillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniae

    Clinical Microbiology and Infection, Vol. 13, Núm. 9, pp. 937-940

2006

  1. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 2, pp. 349-358

  2. Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 2, pp. 224-229

  3. Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 5, pp. 983-986

2005

  1. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point

    International Journal of Antimicrobial Agents, Vol. 25, Núm. 2, pp. 163-167

2001

  1. Prediction of In-vivo efficacy by In-vitro early bactericidal activity with oral β-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin

    Journal of Chemotherapy, Vol. 13, Núm. 2, pp. 118-125